← Back to Search

Sedation for Pain Catastrophizing

Phase < 1
Recruiting
Led By Yun-Yun K Chen, MD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately following procedure
Awards & highlights

Study Summary

This trial investigates pain and psychosocial factors that may affect how patients experience sedation during a nerve block before surgery. A mixed-methods approach will be used to explore patient satisfaction.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately following procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately following procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain scale
Secondary outcome measures
Patient satisfaction

Trial Design

2Treatment groups
Experimental Treatment
Group I: Low Pain CatastrophizingExperimental Treatment2 Interventions
Based on the Pain Catastrophizing Scale (PCS)
Group II: High Pain CatastrophizingExperimental Treatment2 Interventions
Based on the Pain Catastrophizing Scale (PCS)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Midazolam and Fentanyl
2009
Completed Phase 4
~90

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,609 Previous Clinical Trials
11,470,177 Total Patients Enrolled
Yun-Yun K Chen, MDPrincipal InvestigatorBrigham and Women's Hospital
2 Previous Clinical Trials
206 Total Patients Enrolled

Media Library

Low Pain Catastrophizing Clinical Trial Eligibility Overview. Trial Name: NCT05579509 — Phase < 1
Pain Catastrophizing Research Study Groups: Low Pain Catastrophizing, High Pain Catastrophizing
Pain Catastrophizing Clinical Trial 2023: Low Pain Catastrophizing Highlights & Side Effects. Trial Name: NCT05579509 — Phase < 1
Low Pain Catastrophizing 2023 Treatment Timeline for Medical Study. Trial Name: NCT05579509 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could individuals with qualifying conditions enroll in this clinical exploration?

"Confirmative, the information on clinicaltrials.gov reveals that this research is currently open for recruitment. The experiment was initially posted on October 1st 2022 and recently updated January 7th 2023. A total of 150 participants are needed at one location."

Answered by AI

How many participants are enrolled in this clinical trial?

"Affirmative. According to the research posted on clinicaltrials.gov, this medical experiment is currently recruiting patients for participation. Initially shared on October 1st 2022, it was last updated on January 7th 2023 and requires 150 individuals from a single trial site."

Answered by AI
~60 spots leftby Apr 2025